Slco1b2 mRNA decreased to 63% of control in the WT-NASH group, to 44% of control in the Mrp2–/–-NASH group, and was not detected in either of the O−/− groups (Fig. 4A and B, middle left panels). Here, ABCC2 is linked to metabolic dysfunction-associated steatohepatitis.